Effect of transplanted adipose-derived stem cells in mice exhibiting idiopathic pulmonary fibrosis

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 5933-5938

  Jiang, Hongbin ^a,b   Zhang, Jun ^b   Zhang, Zhemin ^b   Ren, Shengxiang ^b   Zhang, Chuansen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adipose derived stem cells; Bleomycin; Idiopathic pulmonary fibrosis; Transplantation

Indexed keywords

BLEOMYCIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE; HYDROXYPROLINE;

ADIPOSE DERIVED STEM CELL; ADIPOSE DERIVED STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLLAGEN FIBER; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM CELL; LUNG PARENCHYMA; MOUSE; NONHUMAN; STEM CELL TRANSPLANTATION; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; CYTOLOGY; DISEASE MODEL; IDIOPATHIC PULMONARY FIBROSIS; LUNG ALVEOLUS CELL; METABOLISM; PATHOLOGY; PROCEDURES; STEM CELL;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; HYDROXYPROLINE; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; PNEUMOCYTES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84940531595     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4178     Document Type: Article

References (26)

1. Tzouvelekis A, Koliakos G, Ntolios P, Baira I, Bouros E, Oikonomou A, Zissimopoulos A, Kolios G, Kakagia D, Paspaliaris V, et al: Stem cell therapy for idiopathic pulmonary fbrosis: a protocol proposal. J Transl Med 9: 182, 2011.
2. D'Agostino B, Sullo N, Siniscalco D, De Angelis A and Rossi F: Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opin Biol Ther 10: 681-687, 2010.
3. Zhang WG, He L, Shi XM, Wu SS, Zhang B, Mei L, Xu YJ, Zhang ZX, Zhao JP and Zhang HL: Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respir Res 15: 33, 2014.
4. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R and Trounson A: Human umbilical cord mesenchymal stem cells reduce fbrosis of bleomycin-induced lung injury. Am J Pathol 175: 303-313, 2009.
5. Gupta N, Su X, Popov B, Lee J W, Serikov V and Matthay MA: Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179: 1855-1863, 2007.
6. Taghi GM, Ghasem Kashani Maryam H, Taghi L, Leili H and Leyla M: Characterization of in vitro cultured bone marrow and adipose tissue-derived mesenchymal stem cells and their ability to express neurotrophic factors. Cell Biol Int 36: 1239-1249, 2012.
7. Nakao N, Nakayama T, Yahata T, Muguruma Y, Saito S, Miyata Y, Yamamoto K and Naoe T: Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo: advantages over bone marrow-derived mesenchymal stem cells. Am J Pathol 177: 547-554, 2010.
8. Ding L, Dolgachev V, Wu Z, Liu T, Nakashima T, Wu Z, Ullenbruch M, Lukacs NW, Chen Z and Phan SH: Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fbrosis. J Pathol 230: 205-214, 2013.
9. Liu HY, Chiou JF, Wu AT, Tsai CY, Leu JD, Ting LL, Wang MF, Chen HY, Lin CT, Williams DF, et al: The effect of diminished osteogenic signals on reduced osteoporosis recovery in aged mice and the potential therapeutic use of adipose-derived stem cells. Biomaterials 33: 6105-6112, 2012.
10. Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH and Drew AF: Bleomycin-induced pulmonary fbrosis in fbrinogen-null mice. J Clin Invest 106: 1341-1350, 2000.
11. Monteiro-Amado F, Castro-Silva II, Lima CJ, Soa res FA, Kowalski LP and Granjeiro JM: Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/microvascular density in squamous cell carcinomas of the foor of the mouth. Braz Dent J 24: 3-9, 2013.
12. Inamdar AC and Inamdar AA: Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell. Exp Lung Res 39: 315-327, 2013.
13. Moodley Y, Manuelpillai U and Weiss DJ: Cellular therapies for lung disease: a distant horizon. Respirology 16: 223-237, 2011.
14. Sdrimas K and Kourembanas S: MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy. Antioxid Redox Signal 21: 1905-1915, 2014.
15. Huleihel L, Levine M and Rojas M: The potential of cell-based therapy in lung diseases. Expert Opin Biol Ther 13: 1429-1440, 2013.
16. Rhieu BH, Epperly MW, Cao S, Franicola D, Shields D, Goff J, Wang H and Greenberger JS: Increased hematopoiesis in long-term bone marrow cultures and reduced irradiation-induced pulmonary fibrosis in Von Willebrand factor homologous deletion recombinant mice. In Vivo 28: 449-456, 2014.
17. Gilpin SE, Lung K, de Couto GT, Cypel M, Sato M, Singer LG, Keshavjee S and Waddell TK: Bone marrow-derived progenitor cells in end-stage lung disease patients. BMC Pulm Med 13: 48, 2013.
18. Aguilar S, Scotton CJ, McNulty K, Nye E, Stamp G, Laurent G, Bonnet D and Janes SM: Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fbrosis. PLoS One 4: e8013, 2009.
19. Kalayarasan S, Sriram N, Soumyakrishnan S and Sudhandiran G: Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fbrosis through the involvement of protease activated receptor-2. Toxicol Appl Pharmacol 271: 184-195, 2013.
20. Rawlins EL: Lung epithelial progenitor cells: lessons from development. Proc Am Thorac Soc 5: 675-681, 2008.
21. Reynolds SD and Malkinson AM: Clara cell: progenitor for the bronchiolar epithelium. Int J Biochem Cell Biol 42: 1-4, 2010.
22. Popova A P, Boz yk PD, Goldsm it h A M, Li nn M J, Lei J, Bentley JK and Hershenson MB: Autocrine production of TGF-beta1 promotes myofbroblastic differentiation of neonatal lung mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol 298: L735-L743, 2010.
23. Sun Z, Wang C, Shi C, Sun F, Xu X, Qian W, Nie S and Han X: Activated Wnt signaling induces myofbroblast differentiation of mesenchymal stem cells, contributing to pulmonary fbrosis. Int J Mol Med 33: 1097-1109, 2014.
24. Lagente V, Manoury B, Nénan S, Le Quément S, Martin-Chouly C and Boichot E: Role of matrix metalloproteinases in the development of airway infammation and remodeling. J Med Biol Res 38: 1521-1530, 2005.
25. Kim J Y, Choeng HC, Ahn C and Cho SH: Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fbrosis. Yonsei Med J 50: 68-77, 2009.
26. Wang Q, Zhu H, Zhou WG, Guo XC, Wu MJ, Xu ZY, Jiang JF, Shen C and Liu HQ: N-acetylcysteine-pretreated human embryonic mesenchymal stem cell administration protects against bleomycin-induced lung injury. Am J Med Sci 346: 113-122, 2013.